- Z79.620 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM Z79.620 became effective on October 1, 2022.
- This is the American ICD-10-CM version of Z79.620 – other international versions of ICD-10 Z79.620 may differ.
Applicable To
- Long term (current) use of adalimumab
- Long term (current) use of etanercept
- Long term (current) use of infliximab
- Long term (current) use of monoclonal antibodies
Code History
- 2024 (effective 10/1/2022): New code
- 2024 (effective 10/1/2022): No change